We have located links that may give you full text access.
Clinic-level factors associated with time to antiretroviral initiation and viral suppression in a large urban cohort.
Clinical Infectious Diseases 2019 November 9
BACKGROUND: Using the results of a site assessment survey performed at clinics throughout Washington DC, we studied the impact of clinic-level factors on antiretroviral therapy (ART) initiation and viral suppression (VS) among people living with HIV (PLWH).
METHODS: This was a retrospective analysis from the DC Cohort, an observational clinical cohort of PLWH from 2011-2018. We included data from PLWH not on ART and not virally suppressed at enrollment. Outcomes were ART initiation and VS (HIV RNA <200 copies/mL). A clinic survey captured information on care delivery (clinical services, adherence services, patient monitoring services, e.g.) and clinic characteristics (types of providers, availability of evenings/weekends sessions, e.g.). Multivariate marginal Cox regression models were generated to identify factors associated with time to ART initiation and VS.
RESULTS: Multiple clinic-level factors were associated with ART initiation, including retention in care monitoring and medication dispensing review (aHR = 1.34 to 1.40, p<0.05 for both). Furthermore, multiple factors were associated with VS, including retention in HIV care monitoring, medication dispensing review, presence of a peer interventionist (aHR ranging from 1.35 to 1.72, p<0.05 for all). In multivariable models evaluating different combinations of clinic-level factors, enhanced adherence services (aHR 1.37 (95% CI 1.18, 1.58), medication dispensing review (aHR 1.22, 95% CI 1,10, 1.36), and availability of opioid treatment (aHR 1.26 (95% CI 1.01, 1.57) were all associated with time to VS.
CONCLUSIONS: The observed association between clinic-level factors and ART initiation/VS suggests that the presence of specific clinic services may facilitate achievement of HIV treatment goals.
METHODS: This was a retrospective analysis from the DC Cohort, an observational clinical cohort of PLWH from 2011-2018. We included data from PLWH not on ART and not virally suppressed at enrollment. Outcomes were ART initiation and VS (HIV RNA <200 copies/mL). A clinic survey captured information on care delivery (clinical services, adherence services, patient monitoring services, e.g.) and clinic characteristics (types of providers, availability of evenings/weekends sessions, e.g.). Multivariate marginal Cox regression models were generated to identify factors associated with time to ART initiation and VS.
RESULTS: Multiple clinic-level factors were associated with ART initiation, including retention in care monitoring and medication dispensing review (aHR = 1.34 to 1.40, p<0.05 for both). Furthermore, multiple factors were associated with VS, including retention in HIV care monitoring, medication dispensing review, presence of a peer interventionist (aHR ranging from 1.35 to 1.72, p<0.05 for all). In multivariable models evaluating different combinations of clinic-level factors, enhanced adherence services (aHR 1.37 (95% CI 1.18, 1.58), medication dispensing review (aHR 1.22, 95% CI 1,10, 1.36), and availability of opioid treatment (aHR 1.26 (95% CI 1.01, 1.57) were all associated with time to VS.
CONCLUSIONS: The observed association between clinic-level factors and ART initiation/VS suggests that the presence of specific clinic services may facilitate achievement of HIV treatment goals.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app